Literature DB >> 26856406

HLA-DQA1/B1 alleles as putative susceptibility markers in congenital toxoplasmosis.

Paulo Tadashi Shimokawa1, Lília Spaleta Targa1, Lidia Yamamoto1, Jonatas Cristian Rodrigues1,2, Kelly Aparecida Kanunfre1,2, Thelma Suely Okay1.   

Abstract

Host and parasite genotypes are among the factors associated with congenital toxoplasmosis pathogenesis. As HLA class II molecules play a key role in the immune system regulation, the aim of this study was to investigate whether HLA-DQA1/B1 alleles are associated with susceptibility or protection to congenital toxoplasmosis. One hundred and twenty-two fetuses with and 103 without toxoplasmosis were studied. The two study groups were comparable according to a number of socio-demographic and genetic variables. HLA alleles were typed by PCR-SSP. In the HLA-DQA1 region, the allele frequencies showed that *01:03 and *03:02 alleles could confer susceptibility (OR= 3.06, p = 0.0002 and OR= 9.60, p= 0.0001, respectively) as they were more frequent among infected fetuses. Regarding the HLA-DQB1 region, the *05:04 allele could confer susceptibility (OR = 6.95, p < 0.0001). Of the 122 infected fetuses, 10 presented susceptibility haplotypes contrasting with only one in the non-infected group. This difference was not statistically significant after correction for multiple comparison (OR = 9.37, p=0.011). In the casuistic, there were two severely damaged fetuses with high parasite loads determined in amniotic fluid samples and HLA-DQA1 susceptibility alleles. In the present study, a discriminatory potential of HLA-DQA1/B1 alleles to identify susceptibility to congenital toxoplasmosis and the most severe cases has been shown.

Entities:  

Keywords:  Congenital toxoplasmosis; Genetic polymorphism; Genetic susceptibility; HLA alleles; polymerase chain reaction

Mesh:

Substances:

Year:  2016        PMID: 26856406      PMCID: PMC4871673          DOI: 10.1080/21505594.2016.1150401

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  37 in total

1.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.

Authors:  O Olerup; H Zetterquist
Journal:  Tissue Antigens       Date:  1992-05

2.  Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii.

Authors:  Stéphane Romand; Muriel Chosson; Jacqueline Franck; Martine Wallon; François Kieffer; Karine Kaiser; Henri Dumon; François Peyron; Philippe Thulliez; Stéphane Picot
Journal:  Am J Obstet Gynecol       Date:  2004-03       Impact factor: 8.661

3.  Congenital toxoplasmosis due to maternal reinfection during pregnancy.

Authors:  M F Gavinet; F Robert; G Firtion; E Delouvrier; C Hennequin; J R Maurin; C Tourte-Schaefer; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

4.  HLA class II involvement in HIV-associated Toxoplasmic encephalitis development.

Authors:  Alicia Habegger de Sorrentino; Roxana López; Patricia Motta; Karina Marinic; Adrián Sorrentino; Ernesto Iliovich; Andrea E Rubio; Jorge Quarleri; Horacio Salomón
Journal:  Clin Immunol       Date:  2005-05       Impact factor: 3.969

Review 5.  Biology and epidemiology of Toxoplasma gondii in man and animals.

Authors:  Dolores E Hill; Sreekumar Chirukandoth; J P Dubey
Journal:  Anim Health Res Rev       Date:  2005-06       Impact factor: 2.615

6.  High-resolution HLA-DQB1 typing using the polymerase chain reaction and sequence-specific primers.

Authors:  C G Mullighan; M Bunce; K I Welsh
Journal:  Tissue Antigens       Date:  1997-12

Review 7.  Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis.

Authors:  A Sensini
Journal:  Clin Microbiol Infect       Date:  2006-06       Impact factor: 8.067

8.  Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease.

Authors:  D K Howe; L D Sibley
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

9.  HLA typing in congenital toxoplasmosis.

Authors:  C Meenken; A Rothova; L P de Waal; A R van der Horst; B J Mesman; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

10.  Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group.

Authors:  I Villena; D Aubert; B Leroux; D Dupouy; M Talmud; C Chemla; T Trenque; G Schmit; C Quereux; M Guenounou; M Pluot; A Bonhomme; J M Pinon
Journal:  Scand J Infect Dis       Date:  1998
View more
  3 in total

Review 1.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

2.  TNFα rs1799964 TT genotype may be a susceptibility factor for vertical transmission of Toxoplasma gondii and clinical signs in newborns from pregnant women with acute toxoplasmosis.

Authors:  Lillian Gonzalez Bonifácio; Mirele Melo; Christiane Maria Ayo; Cinara Cássia Brandão; Letícia Carolina Paraboli Assoni; Larissa Martins Olímpio; Mariana Reis Nogueira; Lígia Cosentino Junqueira Franco Spegiorin; Deusenia Machado Ulisses Barbosa; Luiz Carlos de Mattos; Vera Lucia Pereira-Chioccola
Journal:  Mol Biol Rep       Date:  2022-03-24       Impact factor: 2.742

Review 3.  Human toxoplasmosis in Mozambique: gaps in knowledge and research opportunities.

Authors:  Leonardo Manuel; Gabriela Santos-Gomes; Emilia V Noormahomed
Journal:  Parasit Vectors       Date:  2020-11-11       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.